What does C1A stand for?

Collagen Induced Arthritis (autoimmune disease)

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Committee of 100 for Tibet (Palo Alto, CA) Christian Business Group (Tampa, FL) Concentration at 12 Hours (also seen as C12 h) Commodore 128 (home computer) Table Sugar (sucrose; common chemical formula) Canonicalization (Canonical XML) Commodore 16 (home computer) Circular 175 (interagency process for authorization to negotiate and conclude cooperation agreements; coordinated by US Department of State) Combat 18 International Society for Eighteenth-Century Studies		C1q (Component 1 Subcomponent Q)-Binding Immune Complexes Cadet 1st Class Enhanced CPU State 1 (power-saving mode, computing) C1 Fixation and Transfer Class 1, Generation 2 (EPCglobal, RFID Ceramide-1-Phosphate Complement Component 1, Q Subcomponent (biochemistry) Coated One Side (printing term) Axis (second cervical vertebra; common name) Canoe (two person)

Samples in periodicals archive:

today announced results from a preclinical study evaluating PCI-32765, an orally available, selective inhibitor of Bruton's tyrosine kinase, or Btk, in collagen induced arthritis, an established animal model for rheumatoid arthritis (RA).

Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical ...

Preclinical data to support the use of this class of compounds in collagen induced arthritis (CIA), an animal model for rheumatoid arthritis, was also presented by Dr.

HOLLIS-EDEN REPORTS HE2500 REDUCES PARALYSIS FROM EAE

Data from the collagen induced arthritis animal model studies are expected to be presented at an upcoming scientific conference.

Protalix Reports Preclinical Data on Anti-TNF Follow-on Biologic ...

The Company previously reported positive results from preclinical studies with TRIOLEX in models of collagen induced arthritis (CIA) and collagen antibody induced arthritis (CAIA).

Hollis-Eden Pharmaceuticals Commences Phase I/II Clinical Trial with ...

Food and Drug Administration for a Phase I/II clinical trial in rheumatoid arthritis (RA), has also demonstrated benefit to date in animal models of collagen induced arthritis (CIA), systemic lupus erythematosus, multiple sclerosis and ulcerative colitis without immune suppressive side effects.

Hollis-Eden Pharmaceuticals Presents Data Demonstrating TRIOLEX(TM) ...

Director of Protein Chemistry and Biopharmaceutical Manufacturing at Protalex, will present pre-clinical efficacy data from the collagen induced arthritis study of the Company's PRTX-100 compound in development for the treatment of autoimmune and inflammatory diseases, at the Fifth International Conference on Autoimmunity, taking place November 29- December 3, 2006, at the Hilton Sorrento Palace Hotel, in Sorrento, Italy.

Data from Pre-Clinical Study of Protalex's PRTX-100 Compound to Be ...

NASDAQ:HEPH) today announced data from a preclinical study demonstrating that HE2500, an investigational immune regulating hormone, significantly reduced inflammation in a preclinical model of collagen induced arthritis.

Hollis-Eden Pharmaceuticals Announces HE2500 Significantly Reduces ...

Preclinical data to support the use of this class of compounds in collagen induced arthritis (CIA), an animal model for rheumatoid arthritis, will also be presented by Dr.

Hollis-Eden Pharmaceuticals Announces HE2500 Significantly Reduces ...